Edgewise Therapeutics, Inc. (EWTX)
40.08
+0.55
(+1.39%)
USD |
NASDAQ |
Oct 28, 14:26
Edgewise Therapeutics Price : 40.08 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 39.51 | 40.32 | 39.03 | 39.53 | 942050.0 |
| Oct 26, 2026 | 39.49 | 40.44 | 38.70 | 39.17 | 1.018M |
| Oct 23, 2026 | 39.91 | 39.91 | 38.90 | 39.31 | 911110.0 |
| Oct 22, 2026 | 39.11 | 40.68 | 38.36 | 39.99 | 1.338M |
| Oct 21, 2026 | 39.95 | 40.78 | 39.45 | 39.65 | 1.828M |
| Oct 20, 2026 | 38.03 | 40.32 | 37.88 | 39.75 | 2.171M |
| Oct 19, 2026 | 37.41 | 38.25 | 36.54 | 37.92 | 1.422M |
| Oct 16, 2026 | 38.28 | 38.28 | 36.70 | 37.19 | 1.305M |
| Oct 15, 2026 | 37.62 | 38.53 | 37.24 | 38.20 | 1.837M |
| Oct 14, 2026 | 35.93 | 37.94 | 35.63 | 37.02 | 1.446M |
| Oct 13, 2026 | 38.17 | 38.35 | 36.08 | 36.28 | 810155.0 |
| Oct 12, 2026 | 39.12 | 39.36 | 38.32 | 38.45 | 1.537M |
| Oct 09, 2026 | 39.30 | 40.41 | 38.93 | 39.06 | 1.063M |
| Oct 08, 2026 | 38.14 | 39.41 | 37.24 | 39.23 | 1.364M |
| Oct 07, 2026 | 39.66 | 41.06 | 39.40 | 39.57 | 1.446M |
| Oct 06, 2026 | 40.66 | 41.03 | 39.34 | 40.02 | 1.625M |
| Oct 05, 2026 | 41.55 | 41.79 | 39.98 | 40.30 | 1.634M |
| Oct 02, 2026 | 41.01 | 41.94 | 40.42 | 41.40 | 1.460M |
| Oct 01, 2026 | 40.39 | 41.46 | 39.86 | 40.48 | 1.287M |
| Sep 30, 2026 | 39.49 | 42.12 | 38.89 | 40.60 | 1.678M |
| Sep 29, 2026 | 39.53 | 39.58 | 38.51 | 39.19 | 1.920M |
| Sep 28, 2026 | 39.12 | 40.10 | 39.12 | 39.79 | 2.984M |
| Sep 25, 2026 | 41.59 | 41.99 | 38.57 | 39.34 | 2.488M |
| Sep 24, 2026 | 40.28 | 41.94 | 39.74 | 41.16 | 1.379M |
| Sep 23, 2026 | 44.41 | 44.41 | 39.82 | 41.05 | 2.607M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 0.99 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| Arvinas, Inc. | 7.59 |
| Fulcrum Therapeutics, Inc. | 3.72 |
| Definium Therapeutics, Inc. | 37.76 |
Price Related Metrics
| PEG Ratio | -1.148 |
| Price to Book Value | 9.640 |
| Earnings Yield | -4.61% |
| Market Cap | 4.320B |
| PEGY Ratio | -1.148 |